Technicals

Methode (MEI) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Methode (MEI) reports results for the quarter ended October 2018. While this widely-known consensus outlook is important in gauging the company’s earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on December 6, 2018, might help the stock move higher if these key numbers are better than expectations. […]

Technicals

SAIC (SAIC) Reports Next Week: Wall Street Expects Earnings Growth

The market expects SAIC (SAIC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended October 2018. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 6. […]

Technicals

Michaels (MIK) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Michaels (MIK) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended October 2018. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. […]

Technicals

Signet (SIG) Expected to Beat Earnings Estimates: Should You Buy?

The market expects Signet (SIG) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended October 2018. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 6. […]

Technicals

Earnings Preview: Thor Industries (THO) Q1 Earnings Expected to Decline

Thor Industries (THO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended October 2018. This widely-known consensus outlook gives a good sense of the company’s earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 6 […]

Technicals

Earnings Preview: Peak Resorts (SKIS) Q2 Earnings Expected to Decline

The market expects Peak Resorts (SKIS) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended October 2018. This widely-known consensus outlook is important in assessing the company’s earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on December 6 […]

Technicals

Ulta Beauty (ULTA) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Ulta Beauty (ULTA) reports results for the quarter ended October 2018. While this widely-known consensus outlook is important in gauging the company’s earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on December 6, 2018, might help the stock move higher if these key numbers are better than expectations. […]

Stock Analysts

Precision (PDS) Loses Bidding War, Ensign to Buy Trinidad

The bidding war for Trinidad Drilling Limited finally comes to an end, with Ensign Energy Services beating Precision Drilling Corporation PDS to acquire 56% of Trinidad’s shares. In a bid to cement their market position, two of Canada’s largest drillers — Precision and Ensign — had been competing to acquire their smaller rival Trinidad for quite some time. Notably, Trinidad had started a comprehensive strategic review process early this year, in a bid to contemplate on different strategies to enhance its shareholders’ value. […]

Stock Analysts

Semtech (SMTC) Q3 Earnings Beat Estimates, Revenues Up Y/Y

Semtech Corporation SMTC reported strong fiscal third-quarter 2019 results, wherein earnings and revenues beat the Zacks Consensus Estimate. Non-GAAP earnings of 63 cents per share beat the consensus mark by a couple of cents, and also increased 14.5% sequentially as well as 16.7% year over year. Earnings came within the guided range of 58-64 cents per share. […]

Stock Analysts

Here’s Why You Should Hold Lincoln Electric Stock Right Now

Lincoln Electric Holdings, Inc. LECO is likely to gain from improving end-markets, acquisitions, product launches, execution of the 2020 vision and strategy despite raw material inflation and weak European demand. The company also outpaced the Zacks Consensus Estimate in two of the trailing four quarters, while coming in line in one […]

Stock Analysts

Teva’s Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma

Teva Pharmaceutical Industries Ltd. TEVA and its South-Korean partner Celltrion announced that the FDA has approved their monoclonal antibody (mAb) biosimilar to Roche’s RHHBY blockbuster cancer drug, Rituxan (rituximab). The biosimilar will be available in the United States by the trade name of Truxima (CT-P10) Rituxan is approved to treat Non-Hodgkin’s lymphoma (“NHL”), chronic lymphocytic leukemia, rheumatoid arthritis, Wegener’s granulomatosis and microscopic polyangiitis. […]